Potential complications can be minimised, ensuring that the therapeutic benefits of the medication are realised without compromising your wellbeing
Even traditionally resilient categories such as fresh meat and deli are seeing softer demand, not because consumers are avoiding protein, but because they are simply eating less overall
Lilly Terminates One Obesity Trial of Bimagrumab. BioPharma Dive
These are genuine, peer-reviewed findings from reputable journals
After one year, patients switching from Wegovy maintained about 82% of their prior weight loss, while patients switching from Zepbound maintained about 78%
As more people use these drugs, more people experience the severe side effects that have altered so many peoples lives and led to lawsuits against Novo Nordisk and other pharmaceutical manufacturers